Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.23.1
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Apr. 30, 2023
Mar. 31, 2023
Jan. 17, 2023
Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Marketable equity securities     $ 18,681   $ 18,529
Gross unrealized loss     1,324   1,476
Investments in privately held entities     11,800   11,800
Business Combination, Contingent Consideration, Liability, Current     3,000   $ 2,941
Company X          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration (up to)     3,000    
Company X | Forecast          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Business Combination, Contingent Consideration, Liability, Current $ 300 $ 2,700      
Company Y          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration (up to)     $ 2,600 $ 2,600